EN  |      HE

CT System Engineer - Relocation Position to Denmark


  • CT system engineering (+5 years)
  • CT theory and practice; system integration
  • FDA/MDD Design Control (US and EU regulatory standards)
  • “All the Way” – from Idea to Released Product
  • “Hands on”
  • Corporation with large international partners

Job Description:

  • Member of the R&D team
  • Together with internal and external resources to plan, develop and implement the new products of the company, with focus on CT technology
  • Full responsibility of the specific development project from idea to release and first customer shipment
  • Progress reporting incl financial


  • Ability to lead and motivate – Show the way forward
  • Project management skills
  • Multi-disciplinary (Mechanical, Electro Mechanic, Hardware, Software (PC/Embedded)
  • Minimum fluent in English (verbal/write)
  • Able to be in front of customers
  • Age min. 35 years
  • Internationally exposure
  • Keep promises/high integrity (structured approach)
  • Sense of urgency


  • Willing to relocate to DK.
  • Humor and informal
  • Small organization
  • Interest to continue to build and expand business environment/own position
  • Being able to take full project responsibility new product/targets.

Housing, family relocation (international school) is an option.

Please send resumes in ENGLISH ONLY to



On the recruiting company:

DDD Diagnostic/DENMARK

Founded in Denmark in 1987, DDD-Diagnostic (DDD) has been involved in the design and development of some of the most successful molecular imaging (gamma camera) systems used in the world today by hospitals, imaging centers and clinics in nuclear medicine investigations.


Molecular imaging provides detailed pictures of what is happening inside the body at the molecular and cellular level. Where other diagnostic imaging procedures —such as x-rays, computed tomography (CT) and ultrasound — offer pictures of physical structure, molecular imaging allows physicians to see how the body is functioning and to measure its chemical and biological processes.


Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials to diagnose and treat disease. In nuclear medicine imaging, the radioactive materials are detected by special types of cameras, gamma cameras, which work with computers to provide very precise pictures of the area of the body and/or the function of the organ being imaged.


Molecular imaging procedures are used to diagnose and manage the treatment of cancer, heart disease, brain disorders such as Alzheimer’s and Parkinson’s disease, gastrointestinal disorders, lung disorders, bone disorders, kidney and thyroid disorders, and more.


Over the past 26 years, DDD has become market leader within nuclear cardiology (cardiac imaging), as an OEM manufacturer working with the major international corporations (i.e. Siemens and Philips) and supplying diagnostic imaging equipment worldwide.


In order to further increase and independently manage the growth potential of the company, it was decided in 2012, under the new leadership of Lars Trolle, to develop and establish own branded products, and to establish a Sales and Marketing function and a global distribution network for these products.


As the result of the consequent development and production activities, DDD is presently marketing a range of five, new gamma camera systems through its global network of distributors - in parallel with the established OEM business.


Since the inception of DDD, more than 2,500 DDD gamma cameras have been installed worldwide, and since the recent market introduction of the line extensions/new applications of/to the to the cardiac imaging camera, sales have increased and more than a doubling of the annual turnover is budgeted for the years to come.


In 2013, DDD attracted the attention of the Turkish company Bozlu, a privately owned conglomerate of companies that have nuclear medicine as their core competency. The company has successfully mastered a vertical integration strategy, centered on the nuclear imaging proficiency of the company, and it has experienced tremendous growth, both organically and by means of acquisitions, locally and internationally, to a present size of 1,100 employees.


In a wish to further develop, and to introduce new, molecular imaging devices, by means of combining existing technologies into a single device platform, Bozlu acquired 50% of DDD, and is now, in addition to substantial R&D funding, making the combined competencies of the company within nuclear medicine available to DDD.


As a result, and in recognition of the future need for an even more efficient, project driven and growing R&D organization, the present VP R&D, who is a leading international capacity in the field of gamma cameras, has decided to step aside, into a Senior Specialist position, and a position as Vice President of the Research and Development department at DDD-Diagnostic has consequently become available.


DDD presently counts 31 employees, of which 13 work in the R&D department. The company is situated in pleasant surroundings in the Science Park in Hørsholm.


A recent employee satisfaction survey, conducted by an external company, showed a high degree of satisfaction amongst all employees, across all functions. In the R&D department, and in the company as a whole, there is high level of professional pride and a good team spirit, in the mix of older, highly experienced employees, who have been with the company for many years, and younger, eager-to-learn employees.

The requested position will report to the VP R&D and be a key member in establishing the CT R&D team.